In June 2021, the U.S. Food and Drug Administration approved semaglutide injection for weight loss injection. Advisable for chronic weight management in adults with obesity with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. 

The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 or greater.

Originally used for diabetes and sold under the name Ozempic, a higher dose of the same drug was evaluated for weight loss. During the clinical trials, the average individual lost 15(+) % of their body weight, showing dramatic results.

Semaglutide a weight loss injection, works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake; it is a powerful appetite suppressant. It also works by increasing the production of insulin. Additionally, it inhibits glucagon, which is a hormone that increases blood sugar. 

  1. Delays stomach emptying, leading to a feeling of fullness and smaller meal size
  2. Slows intestinal motility
    Lowers blood sugars
  3. Stimulates insulin secretion by the pancreas

Since the semaglutide weight loss injection does not help increase energy or boost metabolism, we recommend pairing it with either a vitamin b-12 injection or our lipotropic injection

Mild fatigue, intermittent nausea, constipation, and diarrhea. This is not a full list of possible side effects, but the most common we have gotten feedback on. Some are able to be prevented based on water intake and nutrition choices. 

You are NOT a good candidate for semaglutide if you have any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2.


Frequently Asked Questions

Semaglutide, a long-acting analog of the naturally occurring hormone in the body (GLP-1), received FDA approval in 2021 for the treatment of obesity and has been readily prescribed for the treatment of diabetes since 2017.

Glucagon-like peptide-1 (or GLP-1) is a naturally occurring hormone in the body that is secreted in the gut and targets multiple receptors throughout the body related to appetite and hunger.

Almost anyone who has weight to lose and has had difficulty losing the weight on their own could possibly be a candidate for this therapeutic regimen.

During your consultation, we will discuss the specific protocol, but generally, this involves administering progressively increasing doses through once-a-week subcutaneous injections.

The length of treatment depends on the amount of weight you desire to lose and the guidance from the physician.

No, you should not feel energy deficient while taking Semaglutide.

Most patients do not experience issues with uncontrolled hunger. You will find even smaller servings to be completely satisfying.

While a healthy diet is recommended, there are no specific food restrictions.

Yes. There are no exercise restrictions on this diet program.

Patients commonly report light nausea, diarrhea, or constipation as side effects. Healthcare providers can make dosage adjustments to help reduce these effects throughout the treatment regimen.

Contact Us